Correction to “Modeling Antibody Kinetics Post‐mRNA Booster Vaccination and Protection Durations Against SARS‐CoV‐2 Infection”

Documenti analoghi

• Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
  di: Kunpeng Liu, et al.
  Pubblicazione: (2025)
• Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization
  di: Cèlia Torres, et al.
  Pubblicazione: (2025)
• SARS‐CoV‐2‐Induced PAPOLG Contributes to Inflammation Response by Stabilizing NF‐κB mRNA
  di: Yanyan Liao, et al.
  Pubblicazione: (2025)
• Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
  di: Swapna Thomas, et al.
  Pubblicazione: (2024)
• The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients
  di: Yi‐Ju Chan, et al.
  Pubblicazione: (2024)